Effect of Cognitive Behavioral Therapy in OCD Highlighted by Neuropsychological Tests and MRI: Pathophysiology and Treatment Outcome Predictors

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Aarhus
ClinicalTrials.gov Identifier:
NCT00792038
First received: November 14, 2008
Last updated: August 1, 2012
Last verified: August 2012

November 14, 2008
August 1, 2012
January 2009
July 2012   (final data collection date for primary outcome measure)
Y-Bocs [ Time Frame: Before and after treatment approx 20 weeks apart ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00792038 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Effect of Cognitive Behavioral Therapy in OCD Highlighted by Neuropsychological Tests and MRI: Pathophysiology and Treatment Outcome Predictors
Effect of Cognitive Behavioral Therapy in OCD Highlighted by Neuropsychological Tests and MRI: Pathophysiology and Treatment Outcome Predictors

OCD patients are assessed before and after treatment using diagnostic tools, rating scales neuropsychological assessment and functional and structural MR-scans.

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Full blood

Non-Probability Sample

OCD patients from the primary care clinics in middle Jutland, Denmark

Obsessive-Compulsive Disorder
Not Provided
  • 1
    OCD patients
  • 2
    Normal Controls
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
88
July 2012
July 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

1. Steady state medication 3 months prior to the study

Exclusion Criteria:

  1. History of head trauma or other organic brain disease
  2. Pregnancy.
  3. Pacemaker or other ferromagnetic materials in the body.
  4. Comorbid psychiatric illnesses assessed using SCAN- interview (30) other than moderate depression (Ham-D<17) or anxiety disorders.
  5. Antipsychotics
Both
18 Years to 65 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Denmark
 
NCT00792038
M-20080161
Yes
University of Aarhus
University of Aarhus
Not Provided
Principal Investigator: Tue BH Hartmann Aarhus University Hospital, Risskov
Study Director: Sanne Kjær Aarhus University Hospital, Risskov
University of Aarhus
August 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP